The Latest Breaking News from Zacks SCR

AMTI: AMTI is Underappreciated

By Brad Sorensen, CFA NASDAQ:AMTI READ THE FULL AMTI RESEARCH REPORT

Benzinga · Apr 19, 2022

RGC: Regencell Bioscience - Investigational Liquid-Formula RGC-COV19™ Shows Promise in Eliminating COVID-19 Symptoms

By Beth Senko, CFA NASDAQ:RGC

Benzinga · Apr 14, 2022

BTAI: IGALMI™ Approved by the FDA…

By David Bautz, PhD NASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT

Benzinga · Apr 13, 2022

RFHRF: Renforth Resources Releases Assay Results of December's 7-hole Drilling Program Targeting Victoria West on the Surimeau District Property.

By Steven Ralston, CFA OTC:RFHRF | CSE:RFR

Benzinga · Apr 7, 2022

ENSC: Ensysce Releases Encouraging Financials

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT

Benzinga · Apr 6, 2022

CLSN: DSMB Recommends Continuing to Dose Patients in OVATION 2 Study…

By David Bautz, PhD NASDAQ:CLSN READ THE FULL CLSN RESEARCH REPORT

Benzinga · Apr 5, 2022

GBS: Institutional Review Board Approval for Glucose

By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT

Benzinga · Apr 4, 2022

BCLI: Awaiting Clarity on Regulatory Environment Before Deciding on Next Steps for NurOwn®…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT

Benzinga · Apr 4, 2022

RCRT: Recruiter.com Gets Off to a Slower Start in 2022 as Recruiters Need to Redeploy

By Lisa Thompson NASDAQ:RCRT READ THE FULL RCRT RESEARCH REPORT

Benzinga · Apr 4, 2022

TENX: 2021 Financial and Operational Review

By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT

Benzinga · Apr 1, 2022